Clinical Trials Logo

Hemorrhage clinical trials

View clinical trials related to Hemorrhage.

Filter by:

NCT ID: NCT03417206 Not yet recruiting - Clinical trials for Endoscopic Sinus Surgery

PRD-guided Analgesia During FESS for Intraoperative Blood Loss

FESSPRD
Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The aim of this randomized trial is to assess the utility of Pupillary Dilatation Reflex (PRD) for monitoring pain perception intraoperatively and its influence on intraoperative blood loss, quality of surgical field using Boezaart Bleeding Scale (BBS) in patients undergoing functional sinus surgery (FESS) under total intravenous anaesthesia using propofol or volatile anaesthesia using sevoflurane or desflurane

NCT ID: NCT03383562 Not yet recruiting - Infection Clinical Trials

Daytime Variation of Complication in Gastric and Pancreatic Surgery

Start date: January 1, 2018
Phase: N/A
Study type: Observational

Evaluate the daytime variation of complications in gastric and pancreatic surgery

NCT ID: NCT03366259 Not yet recruiting - Clinical trials for Intrapartum Hemorrhage

Prostaglandins Before Caserean Section

Start date: December 2017
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of our study is to assess the value of administration of prostaglandins before cesarean section to reduce the amount of blood loss

NCT ID: NCT03358654 Not yet recruiting - Knee Osteoarthritis Clinical Trials

Evaluating Safety and Efficacy of Mesenchymal Stem Cells From Umbilical Cord

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

This study was to evaluate the safety and efficacy of Mesenchymal Stem Cells (MSCs) from umbilical cord in the treatment of 7 knee OA patients by assessing unexplained local and systemic symptoms or death before and at 1, 2, 3, 6 months after the injection.

NCT ID: NCT03354026 Not yet recruiting - Clinical trials for Traditional Chinese Medicine

Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy

CERBSTTSCH
Start date: November 2017
Phase: Phase 4
Study type: Interventional

The purpose of this research is to use the "Removing Blood Stasis Decotion" of traditional Chinese medicine treating the acute stage of cerebral hemorrhage with stroke associated pneumonia to explore the impact of "Removing Blood Stasis Therapy" on intestinal microbial flora either within the time window from 6 to 72 hours onset.

NCT ID: NCT03310060 Not yet recruiting - Total Blood Loss Clinical Trials

Reducing Blood Loss Using Tisseel in TKA

Start date: November 1, 2017
Phase: Phase 4
Study type: Interventional

The purpose of this study is to conduct a prospective randomized controlled trial to investigate the blood-conservation effect of the topical hemostatic agents in patients receiving primary TKA procedures. The investigators will also observe if there is increased risk of blood transfusion rate by using topical hemostatic agents or not.

NCT ID: NCT03271697 Not yet recruiting - Clinical trials for Aneurysmal Subarachnoid Hemorrhage

Astragalus Membranaceus on Aneurysmal Subarachnoid Hemorrhage

AMASH
Start date: September 2017
Phase: Phase 2/Phase 3
Study type: Interventional

This research is trying to see if AM can enhance the clinical prognosis for spontaneous aneurysm ruptured subarachnoid hemorrhage patients.

NCT ID: NCT03265990 Not yet recruiting - Clinical trials for Ligature; Hemorrhage

Haemorrhoidectomy by Ligasure and Conventional Surgery

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

Comparison between Haemorrhoidectomy by Ligasure and conventional surgery

NCT ID: NCT03246607 Not yet recruiting - Clinical trials for Traumatic Brain Injury

Venous and Cerebral Glucose Microdialysis in Neurocritical Care: Validation & Correlation

Start date: January 26, 2020
Phase:
Study type: Observational

This study evaluates the validity of an intravascular continuous glucose monitoring microdialysis probe, and compares the values to routinely inserted cerebral glucose microdialysis to evaluate the hypothesised relationship between intracranial and intravascular glucose levels.

NCT ID: NCT03243240 Not yet recruiting - Clinical trials for Gastrointestinal Bleeding

Computed Tomography in Gastrointestinal Bleeding

Start date: September 1, 2017
Phase: N/A
Study type: Observational

Gastrointestinal bleeding represents a serious clinical problem and a common cause of hospitalisation with a mortality rate of 6-10% for upper Gastrointestinal bleeding and of 4% for lower Gastrointestinal bleeding requires a multidisciplinary approach involving gastroenterologists, endoscopists, surgeons and radiologists. Gastrointestinal bleeding is self-limited in 80% of cases requiring only supportive measures. However, the persistence of bleeding represents a diagnostic challenge to locate the site of bleeding especially in severe bleeding and to determine, if possible its cause. This will allow to select the most appropriate therapeutic approach in order to reduce the morbidity and mortality, the length of hospitalisation and the transfusion requirements. Current diagnostic algorithms vary widely from institution to institution and from clinician to clinician. Imaging modalities remain the mainstay of the diagnostic approach. They include endoscopy, video capsule, radionuclide imaging, catheter angiography and multidetector computed tomography imaging. In recent years, Multidetector computed tomography has emerged as a promising technology to evaluate Gastrointestinal bleeding. The modality's ease of use and rapid results favour its use in any emergent situation. In addition, today's high-speed, narrow collimation multi-detector technology allows a large coverage area with minimal motion artifacts, with the ability to capture both arterial and venous phase with ease. Multidetector computed tomography is being increasingly used as this is a widely available, non-invasive and fast diagnostic technique that allows for visualisation of the entire intestinal tract and its lesions, the identification of vascularity and possible vascular abnormalities.